KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed May 3, 2017
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-05-01$5.97/sh−1,441$8,603→ 144,963 total
Footnotes (2)
- [F1]Sale of a total of 1,441 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 4,480 shares of restricted stock on April 28, 2017. Mr. Holmes had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 98,850 shares of restricted stock.